Form 4 Filing for ARS Pharmaceuticals, Inc. - Insider Transaction

This filing details a Form 4 document submitted by Pratik Shah, a director at ARS Pharmaceuticals, Inc. (SPRY). The transaction, dated June 24, 2026, involved the acquisition of 30,000 stock options with a right to buy at a price of $0.00 per share. These options are for the underlying Common Stock. The shares subject to the option will vest in full on the earlier of June 24, 2027, or the date of the Issuer's 2027 annual meeting of stockholders. Following this transaction, Mr. Shah holds 30,000 shares. The filing was signed by Kathleen Scott as Attorney-in-Fact on June 26, 2026.